Kintara Therapeutics Inc (KTRA) Insider Trading
Total insider buys:
- $512,604.24
Total insider sells:
- $0.00
Most recent insider trade:
- Dec. 8, 2021
Most active insider trader:
- Jeffrey Bacha
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 8, 2021 | CFO | 28,700 | $0.68 | Buy | $19,516.00 | |
Dec. 6, 2021 | Insider | 11,891 | $0.59 | Buy | $7,015.69 | |
Nov. 22, 2021 | Director | 3,000 | $0.74 | Buy | $2,220.00 | |
Sept. 13, 2019 | Director | 35,000 | $0.68 | Buy | $23,800.00 | |
Nov. 16, 2017 | Director | 20,000 | $0.81 | Buy | $16,200.00 | |
Nov. 14, 2017 | CEO | 60,900 | $0.82 | Buy | $49,938.00 | |
Oct. 6, 2017 | CEO | 10,000 | $0.87 | Buy | $8,700.00 | |
Oct. 5, 2017 | Insider | 17,500 | $0.85 | Buy | $14,875.00 | |
June 26, 2017 | CEO | 6,700 | $3.60 | Buy | $24,120.00 | |
June 26, 2017 | Director | 4,167 | $3.60 | Buy | $15,001.20 | |
June 6, 2017 | CEO | 5,000 | $2.12 | Buy | $10,600.00 | |
June 6, 2017 | Director | 10,000 | $2.12 | Buy | $21,200.00 | |
June 6, 2017 | CFO | 9,500 | $2.10 | Buy | $19,950.00 | |
May 5, 2017 | CEO | 2,500 | $2.20 | Buy | $5,500.00 | |
Feb. 1, 2017 | CEO | 4,000 | $5.00 | Buy | $20,000.00 | |
Nov. 25, 2015 | CEO | 7,500 | $1.47 | Buy | $11,025.00 | |
Oct. 8, 2015 | CEO | 3,000 | $0.80 | Buy | $2,400.00 | |
Sept. 18, 2015 | CEO | 4,000 | $0.83 | Buy | $3,320.00 | |
July 22, 2015 | Major Shareholder | 75,000 | $0.60 | Buy | $45,000.00 | |
July 16, 2015 | CEO | 50,000 | $0.60 | Buy | $30,000.00 | |
July 16, 2015 | Director | 16,666 | $0.60 | Buy | $9,999.60 | |
Jan. 22, 2015 | CEO | 7,500 | $0.66 | Buy | $4,950.00 | |
Dec. 9, 2014 | CEO | 2,500 | $0.90 | Buy | $2,250.00 | |
Nov. 26, 2014 | CEO | 2,500 | $0.92 | Buy | $2,300.00 | |
Nov. 21, 2014 | Director | 8,000 | $0.95 | Buy | $7,600.00 | |
Sept. 18, 2014 | CEO | 4,000 | $0.98 | Buy | $3,920.00 | |
Sept. 15, 2014 | CEO | 4,985 | $0.75 | Buy | $3,738.75 | |
Sept. 8, 2014 | Director | 7,000 | $0.71 | Buy | $4,970.00 | |
Sept. 4, 2014 | Director | 8,000 | $0.78 | Buy | $6,240.00 | |
April 22, 2014 | Director | 20,000 | $1.25 | Buy | $25,000.00 | |
March 18, 2014 | Major Shareholder | 10,000 | $1.30 | Buy | $13,000.00 | |
March 18, 2014 | Director | 25,000 | $1.30 | Buy | $32,500.00 | |
March 4, 2014 | Major Shareholder | 5,000 | $1.56 | Buy | $7,800.00 | |
Feb. 21, 2014 | CEO | 5,000 | $1.00 | Buy | $5,000.00 | |
Feb. 13, 2014 | CEO | 5,000 | $0.80 | Buy | $4,000.00 | |
Feb. 11, 2014 | Director | 9,000 | $0.83 | Buy | $7,470.00 | |
Feb. 5, 2014 | Director | 9,000 | $0.88 | Buy | $7,920.00 | |
Jan. 31, 2014 | Director | 2,000 | $0.87 | Buy | $1,740.00 | |
Jan. 29, 2014 | Director | 7,500 | $0.91 | Buy | $6,825.00 | |
Sept. 20, 2013 | Director | 5,000 | $1.00 | Buy | $5,000.00 |
First«1 of 1»Last
Insiders are buying Kintara Therapeutics Inc stock.
The insider traders at Kintara Therapeutics Inc are: Jeffrey Bacha, John K Bell, Robert Joseph Toth Jr, Dennis M Brown, William J Garner, Scott Praill, Saiid Zarrabian, Laura L Johnson, and Anthony Scott Praill
The most active insider trader at Kintara Therapeutics Inc is Jeffrey Bacha with 16 trades.
John K Bell has bought the most Kintara Therapeutics Inc stock with a total value of $151,281.20.
The most recent insider trade for Kintara Therapeutics Inc was on Dec. 8, 2021.
The single biggest insider buy for Kintara Therapeutics Inc was from Saiid Zarrabian with a total value of $49,938.00 on Nov. 14, 2017.